Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine

JAMA Dermatol. 2021 Sep 1;157(9):1128-1130. doi: 10.1001/jamadermatol.2021.2474.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / adverse effects*
  • Dermatologic Agents / administration & dosage
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / drug therapy
  • Drug Eruptions / immunology
  • Drug Eruptions / pathology
  • Drug Therapy, Combination
  • Facial Dermatoses / diagnosis*
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / immunology
  • Facial Dermatoses / pathology
  • Humans
  • Male
  • Middle Aged
  • Neutrophils / immunology*
  • Rosacea / diagnosis
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • Skin / immunology
  • Skin / pathology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • COVID-19 Vaccines
  • Dermatologic Agents
  • mRNA-1273 vaccine